Page results
-
The autumn/winter edition of Charity Matters is out now.
-
Two clinicians with close links to UCLH and UCL have been appointed to be National Clinical Directors (NCD) by NHS England (NHSE) for 2024.
-
Two UCLH nurses who have dedicated their entire career to the NHS were invited to attend a VE Day celebration concert last Thursday.
-
The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.
-
A groundbreaking e-learning course dedicated to improving care and understanding of Sickle Cell Disorder (SCD) has been officially launched, marking a significant milestone in the fight against health inequalities.
-
A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.
-
The Patient Advice and Liaison Service (PALS) provides impartial advice and assistance in answering questions and resolving concerns that patients, their relatives, friends and carers might have accessing the NHS services provided by UCLH.
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
A huge thank you and well done to everyone who ran the London Marathon last weekend to support UCLH.
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
File results
-
FOI/2022/0530 - Neonatal sepsis guidance
-
FOI/2022/0531 - Operating theatres in Trust
-
FOI/2022/0533 - Pathology service carrying out PCR testing for SARS-CoV2
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology